RIFLE Criteria and AKIN Classification

OVERVIEW

  • AKI can be defined as an abrupt (1 to 7 days) and sustained (more than 24 hours) decrease in kidney function.
  • Over 30 definitions of acute renal failure/AKI have been used in the literature.
  • The ADQI formulated the RIFLE criteria in 2004 to allow for AKI to be objectively and uniformly defined.

RIFLE CRITERIA

RIFLE criteria

IMPLICATIONS

The implication of this classification is that a progression down the RIFLE criteria is associated with:

  • increased LOS in ICU
  • increased LOS in Hospital
  • higher mortality
  • lower renal recovery (for example, higher serum creatinine at hospital discharge)

AKI can be present with a normal creatinine, if it is sufficiently elevated above baseline.

LIMITATIONS

  • Retrospective tool — need to measure changes in Cr and UO over time
  • Requires baseline creatinine— ADQI recommends a creatinine estimation based on the Modification of Diet in Renal Disease (MDRD) formula, assuming a normal GFR of approximately 75 to 100 ml/min/1.73 m2 (but this may not be valid)
  • Accuracy of urine output measures
  • Urine output affected by many factors such as: — the use of diuretics — ADH response — diabetes insipidis
  • Baseline creatinine may be affected by the patients concurrent health problem e.g. it may be falsely high purely because the patient was dehydrated on admission
  • It is uncertain how well balanced urine output and creatinine are even though they have been given an equal weighting (RIFLE using creatinine have higher mortality than if using UO)
  • smaller changes in creatinine than those specified under class Risk (e.g. Cr increase by 0.3 mg/dl) are associated with worse outcomes (see AKIN modifciation)
  • Novel renal biomarkers, in the future, may be able to detect injury earlier
  • Does not consider the nature or site of AKI

AKIN CLASSIFICATION

In 2007 the AKI Network proposed the following changes to the RIFLE criteria:

  • proposed that stages 1, 2 and 3 be used instead of R, I and F; L and E are discarded
  • broadening of the ‘risk’ category of RIFLE to include increase in serum creatinine of at least 0.3 mg/dl even if this does not reach 1.5x the baseline creatinine
  • Cr measurements had to be measured within a 48h window (this may miss AKI that progresses more slowly) — baseline creatinine is replaced by the reference creatinine (the first Cr measured) — however it is recommended that “staging take place over a longer period (e.g. 7 days)”
  • categorizing patients as ‘failure’ (stage 3) if they are treated with RRT regardless of what their serum creatinine or urine output is at the point of initiation (this may be confounding)
  • GFR was discarded (used as an alternative to Cr in the original RIFLE criteria. causing additional variation based on its calculation)
  • Diagnostic criteria to be used only “after an optimal state of hydration has been achieved” and “easily reversible causes” (such as urinary obstruction) should be excluded

Overall, the AKIN modification does not perform better than the RIFLE criteria in studies. Either may be used.


References and Links

  • ADQI – Acute Dialysis Quality Initiative
  • Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative workgroup. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004 Aug;8(4):R204-12. PMC522841.
  • Cruz DN, Ricci Z, Ronco C. Clinical review: RIFLE and AKIN–time for reappraisal. Crit Care. 2009;13(3):211. PMC2717405.
  • Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A; Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31. PMC2206446.
  • Srisawat N, Hoste EE, Kellum JA. Modern classification of acute kidney injury. Blood Purif. 2010;29(3):300-7. PMID: 20130395.

CCC 700 6

Critical Care

Compendium

Chris is an Intensivist and ECMO specialist at the Alfred ICU in Melbourne. He is also the Innovation Lead for the Australian Centre for Health Innovation at Alfred Health and Clinical Adjunct Associate Professor at Monash University. He is a co-founder of the Australia and New Zealand Clinician Educator Network (ANZCEN) and is the Lead for the ANZCEN Clinician Educator Incubator programme. He is on the Board of Directors for the Intensive Care Foundation and is a First Part Examiner for the College of Intensive Care Medicine. He is an internationally recognised Clinician Educator with a passion for helping clinicians learn and for improving the clinical performance of individuals and collectives.

After finishing his medical degree at the University of Auckland, he continued post-graduate training in New Zealand as well as Australia’s Northern Territory, Perth and Melbourne. He has completed fellowship training in both intensive care medicine and emergency medicine, as well as post-graduate training in biochemistry, clinical toxicology, clinical epidemiology, and health professional education.

He is actively involved in in using translational simulation to improve patient care and the design of processes and systems at Alfred Health. He coordinates the Alfred ICU’s education and simulation programmes and runs the unit’s education website, INTENSIVE.  He created the ‘Critically Ill Airway’ course and teaches on numerous courses around the world. He is one of the founders of the FOAM movement (Free Open-Access Medical education) and is co-creator of litfl.com, the RAGE podcast, the Resuscitology course, and the SMACC conference.

His one great achievement is being the father of two amazing children.

On Twitter, he is @precordialthump.

| INTENSIVE | RAGE | Resuscitology | SMACC

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.